Arcutis Biotherapeutics (ARQT) Other Non-Current Liabilities (2019 - 2026)
Arcutis Biotherapeutics' Other Non-Current Liabilities came in at $431,000 for Q2 2026, up 19.7% from $360,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Going back to Q4 2019, Arcutis Biotherapeutics' Other Non-Current Liabilities data covers 22 quarters.
- Other Non-Current Liabilities carries a five-year compound annual growth rate of 39.4% (FY2020 to FY2025).
- Going back by year, Other Non-Current Liabilities was $570,000 in FY2024 (-32.9%), $849,000 in FY2023 and $25,000 in FY2021 (-69.5%).
- The five-year range for quarterly Other Non-Current Liabilities is $12,000 (Q2 2022) to $849,000 (Q4 2023).
- Year-over-year, Other Non-Current Liabilities increased in four of the last seven quarters, with growth averaging 10.2%.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2025 (growth of 85.6%), and the weakest in Q3 2021 (a decline of 72.6%).
- Business Quant data shows ARQT's Other Non-Current Liabilities at $431,000 (Q1 2026), $431,000 (Q4 2025) and $360,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Arcutis Biotherapeutics | 3.32 Bn | 2.60 Bn | 118.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 431,000.00 |
| Mar 31, 2026 | 431,000.00 |
| Dec 31, 2025 | 431,000.00 |
| Sep 30, 2025 | 360,000.00 |
| Jun 30, 2025 | 360,000.00 |
| Mar 31, 2025 | 360,000.00 |
| Dec 31, 2024 | 570,000.00 |
| Sep 30, 2024 | 420,000.00 |
| Jun 30, 2024 | 194,000.00 |
| Mar 31, 2024 | 306,000.00 |
| Dec 31, 2023 | 849,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Mar 31, 2021 | 58,000.00 |
| Dec 31, 2020 | 82,000.00 |
| Sep 30, 2020 | 113,000.00 |
| Jun 30, 2020 | 156,000.00 |
API Access
Arcutis Biotherapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();